GSK vet Deb­o­rah Wa­ter­house takes CEO spot at Vi­iv; Is Sanofi pon­der­ing an Acte­lion bid?

GSK in­sid­er Deb­o­rah Wa­ter­house, cur­rent­ly an SVP run­ning the pri­ma­ry care ops of the US phar­ma di­vi­sion, has been tapped as the new CEO of Vi­iv, an am­bi­tious joint ven­ture fo­cused on HIV. A 20-year vet­er­an, Wa­ter­house is tak­ing the place of Do­minique Limet, who de­parts at the end of March. Vi­iv has been able to make sig­nif­i­cant progress in adding new prod­ucts and grow­ing sales, mak­ing it a key part of the GSK or­ga­ni­za­tion. It’s part­nered with Pfiz­er on the group.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.